Challenges and Opportunities in the Application of Abdominal Imaging

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nuclear Medicine & Radiology".

Deadline for manuscript submissions: 25 June 2024 | Viewed by 1623

Special Issue Editors


E-Mail Website
Guest Editor
Department of General and Emergency Radiology, “Antonio Cardarelli” Hospital, A. Cardarelli St. 9, 80131 Naples, Italy
Interests: emergency medicine; radiology; diagnostic imaging; abdominal imaging; body imaging; CT; MRI; US

E-Mail
Guest Editor
Department of General and Emergency Radiology, “Antonio Cardarelli” Hospital, A. Cardarelli St. 9, 80131 Naples, Italy
Interests: emergency radiology; diagnostic imaging; abdominal imaging; body imaging; CT; MRI; US
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear colleagues,

Technological advancements in diagnostic and therapeutic imaging have progressively developed in the last decade in the most varied areas of abdominal pathology, increasingly becoming organ-specific and organ pathology imaging.

This Special Issue takes a close look at the challenges and advances in diagnostic abdominal imaging and imaging-guided therapeutic instances in different clinical scenarios, both traditional and experimental, with careful analyses of the increasingly widespread use of artificial intelligence abdominal applications.

Authors can submit original articles, reviews, or short communications. We encourage submissions from clinical, translational, and basic research that focus on the challenges and opportunities in the application of abdominal imaging.

Dr. Marco Di Serafino
Dr. Francesca Iacobellis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • abdominal imaging
  • diagnostic imaging
  • interventional radiology
  • endovascular therapy
  • artificial intelligence

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

13 pages, 2926 KiB  
Article
MRI Assessment of Cesarean Scar Pregnancies: A Case Series
by Rosita Comune, Carlo Liguori, Stefania Tamburrini, Francesco Arienzo, Luigi Gallo, Federica Dell’Aversana, Filomena Pezzullo, Fabio Tamburro, Pietro Affinito and Mariano Scaglione
J. Clin. Med. 2023, 12(23), 7241; https://doi.org/10.3390/jcm12237241 - 22 Nov 2023
Viewed by 924
Abstract
Cesarean scar pregnancies (CSPs) are a type of ectopic pregnancy that occur when an embryo implants within the fibrous scar tissue of a previous cesarean surgery. If not promptly detected and treated, CSPs can result in serious maternal complications, such as uterine rupture [...] Read more.
Cesarean scar pregnancies (CSPs) are a type of ectopic pregnancy that occur when an embryo implants within the fibrous scar tissue of a previous cesarean surgery. If not promptly detected and treated, CSPs can result in serious maternal complications, such as uterine rupture and hemorrhage. TVUS (transvaginal ultrasonography) represents the imaging of choice for the diagnosis of CSPs; however, recent studies proposed a complementary role of MRI due to its capability in soft tissue characterization that may impact the therapeutical decision-making process. The purpose of our study was to explore the role of MRI in the diagnosis and its impact on therapeutical options in CSPs. Our experience showed that MRI has a complementary role to TVSU in correctly diagnosing CSPs, identifying the type, and guiding the therapeutical approach. Full article
(This article belongs to the Special Issue Challenges and Opportunities in the Application of Abdominal Imaging)
Show Figures

Figure 1

Review

Jump to: Research

24 pages, 13384 KiB  
Review
Safe and Informed Use of Gadolinium-Based Contrast Agent in Body Magnetic Resonance Imaging: Where We Were and Where We Are
by Francesca Iacobellis, Marco Di Serafino, Camilla Russo, Roberto Ronza, Martina Caruso, Giuseppina Dell’Aversano Orabona, Costanza Camillo, Vittorio Sabatino, Dario Grimaldi, Chiara Rinaldo, Luigi Barbuto, Francesco Verde, Giuliana Giacobbe, Maria Laura Schillirò, Enrico Scarano and Luigia Romano
J. Clin. Med. 2024, 13(8), 2193; https://doi.org/10.3390/jcm13082193 - 10 Apr 2024
Viewed by 429
Abstract
Gadolinium-based contrast agents (GBCAs) have helped to improve the role of magnetic resonance imaging (MRI) for the diagnosis and treatment of diseases. There are currently nine different commercially available gadolinium-based contrast agents (GBCAs) that can be used for body MRI cases, and which [...] Read more.
Gadolinium-based contrast agents (GBCAs) have helped to improve the role of magnetic resonance imaging (MRI) for the diagnosis and treatment of diseases. There are currently nine different commercially available gadolinium-based contrast agents (GBCAs) that can be used for body MRI cases, and which are classifiable according to their structures (cyclic or linear) or biodistribution (extracellular-space agents, target/specific-agents, and blood-pool agents). The aim of this review is to illustrate the commercially available MRI contrast agents, their effect on imaging, and adverse reaction on the body, with the goal to lead to their proper selection in different clinical contexts. When we have to choose between the different GBCAs, we have to consider several factors: (1) safety and clinical impact; (2) biodistribution and diagnostic application; (3) higher relaxivity and better lesion detection; (4) higher stability and lower tissue deposit; (5) gadolinium dose/concentration and lower volume injection; (6) pulse sequences and protocol optimization; (7) higher contrast-to-noise ratio at 3.0 T than at 1.5 T. Knowing the patient’s clinical information, the relevant GBCAs properties and their effect on body MRI sequences are the key features to perform efficient and high-quality MRI examination. Full article
(This article belongs to the Special Issue Challenges and Opportunities in the Application of Abdominal Imaging)
Show Figures

Figure 1

Back to TopTop